Targeting Intracellular Mycobacteria Using Nanosized Niosomes Loaded with Antibacterial Agents
Open Access
- 1 August 2021
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (8) , 1984
Abstract
Background: Pathogenic intracellular mycobacteria are challenging to treat because of the waxy and complex cell wall characterizing the genus. Niosomes are vesicles with biomimetic cell membrane composition, which allow them to efficiently bind to the eukaryotic cells and deliver their cargo into the cytoplasm. The objective of this study was to develop a new platform based on niosomes loaded with antimicrobial agents to target intracellular mycobacteria. Nanoniosomes were fabricated and loaded with antibiotics and lignin–silver nanoparticles. The efficacy of these nanoniosomes was tested against the intracellular pathogen Mycobacterium abscessus used as a model of infection of human-derived macrophages (THP-1). The cytotoxicity and the immunological response of the agents were tested on THP-1 cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the secretion of pro- and anti-inflammatory cytokines, respectively. Results: M. abscessus was susceptible to the nanoniosomes in infected THP-1 macrophages, suggesting that the nanoniosomes were internalized due to their fusion to the macrophage cellular membrane. Moreover, nanoniosomes showed no upregulation of pro-inflammatory cytokines when exposed to THP-1 macrophages. Conclusions: Nanoniosomes improved drug efficacy while decreasing toxicity and should be considered for further testing in the treatment of intracellular pathogenic mycobacteria or as a new platform for precise intracellular delivery of drugs.Keywords
Funding Information
- BC Lung Foundation (Grant-in-Aid)
- Joint Programming Initiative on Antimicrobial Resistance (01369-000)
This publication has 52 references indexed in Scilit:
- Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophilaInternational Journal of Antimicrobial Agents, 2011
- Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methodsNanotoxicology, 2010
- Formulation andin vitroevaluation of ciprofloxacin containing niosomes for pulmonary deliveryJournal of Microencapsulation, 2010
- Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- History of the Medical Use of SilverSurgical Infections, 2009
- Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to MiceAntimicrobial Agents and Chemotherapy, 2008
- Colloidal silver for lung disease in cystic fibrosisJournal of the Royal Society of Medicine, 2008
- Mycobacterium avium subsp. paratuberculosis PtpA Is an Endogenous Tyrosine Phosphatase Secreted during InfectionInfection and Immunity, 2006
- Fatal Pulmonary Infection Due to Multidrug-Resistant Mycobacterium abscessus in a Patient with Cystic FibrosisJournal of Clinical Microbiology, 2001
- Uptake of ciprofloxacin by macrophages.Journal of Clinical Pathology, 1985